![]() |
Name |
Violapyrone J
|
Molecular Formula | C12H18O3 | |
IUPAC Name* |
4-hydroxy-3-methyl-6-(3-methylpentyl)pyran-2-one
|
|
SMILES |
CCC(C)CCC1=CC(=C(C(=O)O1)C)O
|
|
InChI |
InChI=1S/C12H18O3/c1-4-8(2)5-6-10-7-11(13)9(3)12(14)15-10/h7-8,13H,4-6H2,1-3H3
|
|
InChIKey |
IHTSJVCQAKTIMC-UHFFFAOYSA-N
|
|
Synonyms |
Violapyrone J
|
|
CAS | NA | |
PubChem CID | 146684366 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Molecular Weight: | 210.27 | ALogp: | 3.0 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.828 |
Caco-2 Permeability: | -4.6 | MDCK Permeability: | 0.00002290 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.257 |
Blood-Brain-Barrier Penetration (BBB): | 0.08 | Plasma Protein Binding (PPB): | 95.49% |
Volume Distribution (VD): | 0.741 | Fu: | 6.27% |
CYP1A2-inhibitor: | 0.689 | CYP1A2-substrate: | 0.936 |
CYP2C19-inhibitor: | 0.208 | CYP2C19-substrate: | 0.808 |
CYP2C9-inhibitor: | 0.495 | CYP2C9-substrate: | 0.929 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.687 |
CYP3A4-inhibitor: | 0.024 | CYP3A4-substrate: | 0.198 |
Clearance (CL): | 4.988 | Half-life (T1/2): | 0.649 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.191 |
Drug-inuced Liver Injury (DILI): | 0.29 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.079 | Maximum Recommended Daily Dose: | 0.067 |
Skin Sensitization: | 0.609 | Carcinogencity: | 0.419 |
Eye Corrosion: | 0.314 | Eye Irritation: | 0.647 |
Respiratory Toxicity: | 0.173 |